Show simple item record

dc.contributor.authorGituma, Bernard
dc.date.accessioned2014-11-14T13:35:34Z
dc.date.available2014-11-14T13:35:34Z
dc.date.issued2014
dc.identifier.citationMaster of Medicine in Internal Medicine,en_US
dc.identifier.urihttp://hdl.handle.net/11295/74900
dc.description.abstractDilated cardiomyopathy leading to heart failure is a common worldwide problem associated with significant morbidity and mortality. It is responsible for 10,000 deaths and 46,000 hospitalizations annually in the Unites States of America where it affects 2-3 million people (1). The incidence of congestive heart failure(CHF) is 400,000 cases per year (2) and dilated cardiomyopathy contributes a significant proportion to this number. The reported annual incidence ranges between 5 and 8 cases per 100,000 population. However the exact incidence is underestimated because there are many undiagnosed cases (3). The Framingham study found that 5 years after initial presentation with CHF 42% of women and 62% of men had died (2) . After ischemic heart disease, dilated cardiomyopathy is the most common cause of heart failure in western world (4). DCM is the leading indication for heart transplantation in both adults and children in the West (5, 6).en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.titlePrevalence of electrocardiographic abnormalities in patients with dilated cardiomyopathy at kenyatta national hospitalen_US
dc.typeThesisen_US
dc.description.departmenta Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine, Moi University, Eldoret, Kenya
dc.type.materialen_USen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record